119 related articles for article (PubMed ID: 29970693)
21. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
[TBL] [Abstract][Full Text] [Related]
22. Procaine and procainamide inhibit the Wnt canonical pathway by promoter demethylation of WIF-1 in lung cancer cells.
Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablons DM; You L
Oncol Rep; 2009 Dec; 22(6):1479-84. PubMed ID: 19885602
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance.
Abdelmaksoud-Dammak R; Miladi-Abdennadher I; Saadallah-Kallel A; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Tumour Biol; 2014 Aug; 35(8):7975-82. PubMed ID: 24833087
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc.
Licchesi JD; Van Neste L; Tiwari VK; Cope L; Lin X; Baylin SB; Herman JG
Oncogene; 2010 Nov; 29(44):5923-34. PubMed ID: 20697356
[TBL] [Abstract][Full Text] [Related]
25. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablon DM; You L
Anticancer Res; 2009 Jun; 29(6):2025-30. PubMed ID: 19528461
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Role of RASSF1A, SOX17 and Wif-1 Promoter Methylation Status in Cell-Free DNA of Advanced Gastric Cancer Patients.
Karamitrousis EI; Balgkouranidou I; Xenidis N; Amarantidis K; Biziota E; Koukaki T; Trypsianis G; Karayiannakis A; Bolanaki H; Kolios G; Lianidou E; Kakolyris S
Technol Cancer Res Treat; 2021; 20():1533033820973279. PubMed ID: 33928818
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic silencing of WIF-1 in hepatocellular carcinomas.
Deng Y; Yu B; Cheng Q; Jin J; You H; Ke R; Tang N; Shen Q; Shu H; Yao G; Zhang Z; Qin W
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1161-7. PubMed ID: 20119713
[TBL] [Abstract][Full Text] [Related]
28. Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers.
Yoshino M; Suzuki M; Tian L; Moriya Y; Hoshino H; Okamoto T; Yoshida S; Shibuya K; Yoshino I
Int J Oncol; 2009 Nov; 35(5):1201-9. PubMed ID: 19787276
[TBL] [Abstract][Full Text] [Related]
29. Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma.
Rubin EM; Guo Y; Tu K; Xie J; Zi X; Hoang BH
Mol Cancer Ther; 2010 Mar; 9(3):731-41. PubMed ID: 20197388
[TBL] [Abstract][Full Text] [Related]
30. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
[TBL] [Abstract][Full Text] [Related]
31. Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth.
Lin YC; You L; Xu Z; He B; Yang CT; Chen JK; Mikami I; Clément G; Shi Y; Kuchenbecker K; Okamoto J; Kashani-Sabet M; Jablons DM
Hum Gene Ther; 2007 Apr; 18(4):379-86. PubMed ID: 17472570
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic alteration of the Wnt inhibitory factor-1 promoter is common and occurs in advanced stage of Tunisian nasopharyngeal carcinoma.
Fendri A; Khabir A; Hadri-Guiga B; Sellami-Boudawara T; Daoud J; Frikha M; Ghorbel A; Gargouri A; Mokdad-Gargouri R
Cancer Invest; 2010 Nov; 28(9):896-903. PubMed ID: 20874008
[TBL] [Abstract][Full Text] [Related]
33. [Study of WIF-1 promoter methylation with expressions of β-catenin in acute leukemia].
Wang Y; Zhu CS; Bi KH; Xu WW; Dong L; Hou M
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2858-60. PubMed ID: 22333550
[TBL] [Abstract][Full Text] [Related]
34. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review.
Guo H; Zhou S; Tan L; Wu X; Wu Z; Ran R
Oncotarget; 2017 Jan; 8(2):2550-2557. PubMed ID: 27911280
[TBL] [Abstract][Full Text] [Related]
36. The hypomethylation agent bisdemethoxycurcumin acts on the WIF-1 promoter, inhibits the canonical Wnt pathway and induces apoptosis in human non-small-cell lung cancer.
Liu YL; Yang HP; Zhou XD; Gong L; Tang CL; Wang HJ
Curr Cancer Drug Targets; 2011 Nov; 11(9):1098-110. PubMed ID: 21933103
[TBL] [Abstract][Full Text] [Related]
37. Infrequent hypermethylation of WIF-1 promoter in BCR/ABL-negative myeloproliferative disorders.
Suzuki R; Onizuka M; Kojima M; Shimada M; Tsuboi K; Ogawa Y; Kawada H; Ando K
Tokai J Exp Clin Med; 2007 Dec; 32(4):131-5. PubMed ID: 21318952
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.
Voorham QJ; Janssen J; Tijssen M; Snellenberg S; Mongera S; van Grieken NC; Grabsch H; Kliment M; Rembacken BJ; Mulder CJ; van Engeland M; Meijer GA; Steenbergen RD; Carvalho B
BMC Cancer; 2013 Dec; 13():603. PubMed ID: 24350795
[TBL] [Abstract][Full Text] [Related]
39. Infrequent Wnt inhibitory factor-1 (Wif-1) methylation in chronic lymphocytic leukemia.
Chim CS; Fung TK; Wong KF; Lau JS; Liang R
Leuk Res; 2006 Sep; 30(9):1135-9. PubMed ID: 16427695
[TBL] [Abstract][Full Text] [Related]
40. Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer.
Xie J; Zhang Y; Hu X; Lv R; Xiao D; Jiang L; Bao Q
Med Oncol; 2015 May; 32(5):145. PubMed ID: 25814287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
